HDS CDTR Health IT Core

HDS CDTR 健康 IT 核心

• 批准号: 9186358
• 负责人: PATRICK J O'CONNOR
• 金额: $ 5.35万
• 依托单位: KAISER FOUNDATION RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-01 至 2021-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9186358
• 关键词: Address; Affect; American; Area; Big Data; California; Caring; Centers for Disease Control and Prevention (U.S.); Chronic Disease; Clinical; Clinical Trials; Consult; Databases; Development; Diabetes Mellitus; Diabetes prevention; Faculty; Financial Support; Fostering; Foundations; Funding; Health; Health system; Healthcare; Healthcare Systems; Information Systems; Institutes; Integrated Delivery Systems; Intellectual Property; Intervention; Intervention Studies; Knowledge; Link; Medical; Methods; Mission; Morbidity - disease rate; Morehouse School of Medicine; National Institute of Diabetes and Digestive and Kidney Diseases; Non-Insulin-Dependent Diabetes Mellitus; Observational Study; Online Systems; Paper; Patients; Population; Pragmatic clinical trial; Prevalence; Prevention; Primary Prevention; Provider; Public Health Practice; Publishing; Quality of Care; Recording of previous events; Registries; Research; Research Personnel; Research Project Grants; Resources; San Francisco; Site; Structural Models; Structure; Subgroup; Support System; System; Technology; Translating; Translational Research; Translations; Underrepresented Minority; Underserved Population; United States; Universities; Variant; Work; base; care delivery; collaborative environment; comparative effectiveness; compare effectiveness; cost; diabetes prevention program; diabetes risk; directed attention; distributed data; education research; effective intervention; effectiveness research; ethnic minority population; evidence base; health care delivery; health care disparity; health information technology; high risk; improved; informatics infrastructure; innovation; interoperability; low socioeconomic status; minority investigator; mortality; novel strategies; obesity prevention; prevent; programs; ranpirnase; response; safety net; success; systems research; tool

Diabetes mellitus is a significant health burden in the United States, affecting more than 20,000,000 people and costing more than $100 billion annually. The prevalence of Type 2 diabetes (T2DM) is growing rapidly; the CDC estimates that up to 1/3 of Americans will have diabetes by the year 2050. The burden of T2DM is particularly great among ethnic minority populations and those of lower socioeconomic status. The evidence base for the prevention and care of T2DM is one of the most well-established of any chronic illness: clinical trials have shown the efficacy of cardiometabolic therapies in preventing mortality and morbidity in diabetes, and programs such as the Diabetes Prevention Program (DPP) have demonstrated that diabetes can be prevented in high-risk patients. However, the overall quality of care for diabetes remains sub-optimal, significant disparities in diabetes care and prevention persist, and there are very few effective populationbased efforts to systematically reduce prevent diabetes and reduce diabetes risk. Programs that can effectively translate high-quality, evidence-based diabetes prevention and treatment into widespread practice are desperately needed. In response to this need, diabetes researchers at the Kaiser Permanente Northern California Division of Research, HealthPartners Institute for Education and Research, Harvard Pilgrim Health Care Institute, and the University of California San Francisco (UCSF) created the Health Delivery Systems Center for Diabetes Translational Research (HDS-CDTR) in 2011 (P30 DK092924). This CDTR fosters and supports translational research in diabetes within health care delivery systems affiliated with the Health Care Systems Research Network (formerly known as the HMO Research Network) and with UCSF. The HDS- CDTR brings together a multi-disciplinary network of well-established investigators with a strong history of receiving federal and foundation funding in diabetes translational research. The HDS-CDTR is structured around three Translational Research Cores in the areas of health care disparities; diabetes and obesity prevention; and health information technology. HDS-CDTR investigators have strong relationships with delivery systems, ranging from large integrated delivery systems to networks of safety net providers that serve as key partners for translating effective interventions into real-world clinical settings. Our CDTR will continue to be a strong resource to underresourced delivery systems across the U.S. through its Resource Core, which will continue and expand our support of these systems in their efforts to provide high quality diabetes prevention and care. In addition, the HDS-CDTR is expanding its mission to address disparities through the creation of a new Core for Underserved Populations that will develop a strong partnership with junior and senior Underrepresented Minority (URM) investigators at the Morehouse School of Medicine.

糖尿病是美国的一个重大健康负担，影响超过20，000，000人。 每年花费超过1000亿美元2型糖尿病（T2 DM）的患病率正在增加 疾病预防控制中心估计，到2050年，多达1/3的美国人将患有糖尿病。的负担 2型糖尿病在少数民族人群和社会经济地位较低的人群中尤其严重。的 T2 DM的预防和护理的证据基础是任何慢性疾病中最完善的疾病之一： 临床试验已经显示了心脏代谢疗法在预防心脏病患者的死亡率和发病率方面的功效。 糖尿病，和计划，如糖尿病预防计划（DPP）已经证明，糖尿病可以 预防高危患者。然而，糖尿病护理的总体质量仍然不理想， 在糖尿病的护理和预防方面仍然存在着显著的差距，而且很少有有效的基于人口的 努力系统地减少预防糖尿病和降低糖尿病风险。能够有效地 将高质量的循证糖尿病预防和治疗转化为广泛的实践， 迫切需要的。 为了满足这一需求，凯萨医疗机构北方加州分部的糖尿病研究人员 研究，健康伙伴教育和研究所，哈佛朝圣者医疗保健研究所，和 加州圣弗朗西斯科大学（UCSF）创建了糖尿病健康交付系统中心 2011年的转化研究（HDS-CDTR）（P30 DK 092924）。该CDTR促进并支持翻译 与卫生保健系统研究有关的卫生保健提供系统内的糖尿病研究 网络（以前称为HMO研究网络）和UCSF。HDS-CDTR汇集了 多学科网络的完善的调查人员与一个强大的历史，收到联邦和 基金会资助糖尿病转化研究。HDS-CDTR的结构围绕三个翻译 研究核心领域包括：医疗保健差异;糖尿病和肥胖症预防;以及健康信息 技术. HDS-CDTR研究人员与输送系统有着密切的关系， 向作为主要合作伙伴的安全网提供者网络提供综合交付系统， 将有效的干预措施应用到现实世界的临床环境中。我们的CDTR将继续成为资源不足的强大资源。 通过其资源核心，在美国各地的交付系统，这将继续和扩大我们的 支持这些系统努力提供高质量的糖尿病预防和护理。此外该 HDS-CDTR正在扩大其使命，通过创建一个新的服务不足核心解决不平等问题 将与低年级和高年级代表性不足的少数群体（URM）建立强有力伙伴关系的人口 莫尔豪斯医学院的研究人员。